L-Mind: A Safety and Efficacy Analysis of Tafasitamab in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) Receiving Treatment for at Least 2 Years

Saved in:
Bibliographic Details
Published inBlood Vol. 140; no. Supplement 1; pp. 6596 - 6598
Main Authors Duell, Johannes, Jurczak, Wojciech, Liberati, Anna Marina, Halka, Janusz, Carbó, Esther Pena, Abrisqueta Costa, Pau, Maddocks, Kami J., Dreyling, Martin, Rosenwald, Andreas, Bakuli, Abhishek, Amin, Aasim, Gurbanov, Konstantin, Salles, Gilles
Format Journal Article
LanguageEnglish
Published Elsevier Inc 15.11.2022
Online AccessGet full text

Cover

More Information
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-159983